Global Veterinary Pain Management Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Veterinary Pain Management Market, By Drug Type (Opioids, Morphine, Hydromorphone, Codeine, α2-adrenergic Agonists, Xylazine, Medetomidine, Local Anesthetics, Bupivacaine, Lidocaine, Chloroprocaine, Nonsteroidal Anti-inflammatory Drugs (NSIDs), Etodolac, Fentanyl, Meloxicam, Sedatives, Corticosteroids), Route of Administration (Oral Preparations, Parenteral Preparations), End-User (Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies, Online Pharmacies), Distribution Channel (Veterinary Hospitals and Clinics, Pharmacies) – Industry Trends and Forecast to 2029

Veterinary Pain Management Market

Global Veterinary Pain Management Market Analysis and Size

Pain arising out of surgical procedures in animals is something to be dealt with medications, injections and treatment given by the veterinaries. Additionally, as per the results of the 2017-2018 APPA (American Pet Products Association) National Pet Owners Survey, 10% of dogs and 8% each of cats and birds have undergone surgical procedures. Therefore, it becomes crucial to provide the best pain management therapeutics.  

  • Data Bridge Market Research analyses that the veterinary pain management market is expected to undergo a CAGR of 14.05% during the forecast period. This indicates that the market value, which was USD 1.79 billion in 2021, would rocket up to USD 5.13 billion by 2029. “Veterinary Hospitals and Clinics” dominates the distribution channel segment of the veterinary pain management market owing to the growing number of veterinary hospitals and clinics in the developing economies. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Veterinary Pain Management Market Definition

From the name itself, it is clear that veterinary pain management refers to veterinary therapeutics that is given to the animals in pain. The reason for the pain can be numerous ranging from joint pain, surgical pain, arthritis and cancer. The role of the veterinary is to diagnose the cause of pain and provide the required treatment to the animals.               

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Drug Type (Opioids, Morphine, Hydromorphone, Codeine, α2-adrenergic Agonists, Xylazine, Medetomidine, Local Anesthetics, Bupivacaine, Lidocaine, Chloroprocaine, Nonsteroidal Anti-inflammatory Drugs (NSIDs), Etodolac, Fentanyl, Meloxicam, Sedatives, Corticosteroids), Route of Administration (Oral Preparations, Parenteral Preparations), End-User (Veterinary Hospital Pharmacies, Retail Veterinary Pharmacies, Online Pharmacies), Distribution Channel (Veterinary Hospitals and Clinics, Pharmacies)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Zoetis (US), Elanco (US), Bayer AG (Germany), Norbrook (UK), Ceva (France), Dechra Pharmaceuticals (UK), Assisi Animal Health (US), Merck Sharp & Dohme Corp (Germany), Boehringer Ingelheim International GmbH (Germnay), Virbac (France), IDEXX Laboratories (US), Vetoquinol (France), Evonik Industries AG (Germany), DuPont (US), DSM (Netherlands), Adisseo (China), BASF SE (Germany), ADM (US), Nutreco (Netherlands), Novusint (US), Cargill Incorporated (US), Charoen Pokphand Group (Thailand), Sumitomo Chemical (Japan), Kemin Industries, Inc. (US), and Medtronic (Ireland)

Market Opportunities

  • Growth in the incidence rate of leukaemia
  • Increasing number of road accidents  
  • Rising research and development opportunities

Veterinary Pain Management Market Dynamics

Drivers

  • Rising prevalence of diseases

Growing rate of acute and chronic diseases in animals all around the globe owing to various factors is one of the major factors fostering the growth of the market. For example- growing incidence rate of infectious diseases, deficiency diseases, hereditary diseases (including both genetic diseases and non-genetic hereditary diseases), and physiological diseases in animals is directly and positively influencing the growth of the market.

  • Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted pertaining to the advancements in medical devices is also bolstering the market growth rate.

  • Growing investment for healthcare facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities. Also, rising government initiatives to increase awareness about importance of early diagnosis is yet again bolstering the market growth rate.

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, rising pet population, surging number of road accidents of animals and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, growing awareness about promoting the animal health, rise in the preventive treatments and care facilities for companion animals, increase in the popularity of non-conventional and non-pharmaceutical treatment techniques and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges Global Veterinary Pain Management Market

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, decline in the healthcare expenses in the advancing countries, high costs associated with pet care, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This veterinary pain management market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veterinary pain management market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Veterinary Pain Management Market

COVID-19 has had a significant impact on the market. Drop in the rate of manufacturing of medical devices has adversely affected the revenues. Restriction on the movement, shut down of various facilities and supply chain disruption created a challenge for the market. Further, pet parents are advised to keep a safe distance from their pets to maintain hygiene and reduce the risk of contamination. The impact has been seen in the livestock sector as well.  However, the post pandemic period is expected to bring back the market on its track.

Recent Developments

  • In February 2021, Dechra Pharmaceuticals PLC received rights for marketing Tri-Solfen in Australia and New Zealand under a licensing agreement with Animal Ethics Pty Ltd. Tri-Solfen is used as a routine treatment in reducing pain for farm animals.
  • In July 2020, Boehringer Ingelheim acquired a Belgian biotech company, GST, to strengthen its stem cell capabilities in the Animal Health segment.

Global Veterinary Pain Management Market Scope

The veterinary pain management market is segmented on the basis of drug type, route of administration, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug type

  • Opioids
  • Morphine
  • Hydromorphone
  • Codeine
  • α2-adrenergic Agonists
  • Xylazine
  • Medetomidine
  • Local Anesthetics
  • Bupivacaine
  • Lidocaine
  • Chloroprocaine
  • Nonsteroidal Anti-inflammatory Drugs (NSIDs)
  • Etodolac
  • Fentanyl
  • Meloxicam,
  • Sedatives
  • Corticosteroids

On the basis of drug type, the veterinary pain management market is segmented into opioids, morphine, hydromorphone, codeine, α2-adrenergic agonists, xylazine, medetomidine, local anesthetics, bupivacaine, lidocaine, chloroprocaine, nonsteroidal anti-inflammatory drugs (NSIDs), etodolac, fentanyl, meloxicam, sedatives and corticosteroids. 

Route of administration

  • Oral Preparations
  • Parenteral Preparations

Based on route of administration, the veterinary pain management market is segmented into oral preparations and parenteral preparations. 

End-user

  • Veterinary Hospital Pharmacies
  • Retail Veterinary Pharmacies
  • Online Pharmacies

Based on end-user, the veterinary pain management market is segmented into veterinary hospital pharmacies, retail veterinary pharmacies and online pharmacies. 

Distribution channel

  • Veterinary Hospitals and Clinics
  • Pharmacies

The veterinary pain management market is also segmented on the basis of distribution channel into veterinary hospitals and clinics and pharmacies.

Veterinary Pain Management Market Regional Analysis/Insights

The veterinary pain management market is analysed and market size insights and trends are provided by country, drug type, route of administration, end-user and distribution channel as referenced above.

The countries covered in the veterinary pain management market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the veterinary pain management market because of the strong base of healthcare facilities, rise in the demand for efficient animal care, steady rise in the number of pet owners in this region and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, rising pet population and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The veterinary pain management market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for veterinary pain management market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the veterinary pain management market. The data is available for historic period 2010-2020.

Competitive Landscape and Veterinary Pain Management Market Share Analysis

The veterinary pain management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to veterinary pain management market.

Some of the major players operating in the veterinary pain management market are:

  • Zoetis (US)
  • Elanco (US)
  • Bayer AG (Germany)
  • Norbrook (UK)
  • Ceva (France)
  • Dechra Pharmaceuticals (UK)
  • Assisi Animal Health (US)
  • Merck Sharp & Dohme Corp (Germany)
  • Boehringer Ingelheim International GmbH (Germnay)
  • Virbac (France)
  • IDEXX Laboratories (US)
  • Vetoquinol (France)
  • Evonik Industries AG (Germany)
  • DuPont (US)
  • DSM (Netherlands)
  • Adisseo (China)
  • BASF SE (Germany)
  • ADM (US)
  • Nutreco (Netherlands)
  • Novusint (US)
  • Cargill Incorporated (US)
  • Charoen Pokphand Group (Thailand)
  • Sumitomo Chemical (Japan)
  • Kemin Industries, Inc. (US)
  • Medtronic (Ireland)

Research Methodology : Global Veterinary Pain Management Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-veterinary-pain-management-market

Customization Available : Global Veterinary Pain Management Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Veterinary Pain Management Market Value is expected USD 1,402.94 million by 2029.
The Veterinary Pain Management Market is Projected to Grow at a CAGR of 14.05% During the Forecast Period of 2022 to 2029.
Zoetis (US), Elanco (US), Bayer AG (Germany), Norbrook (UK), Ceva (France), Dechra Pharmaceuticals (UK), Assisi Animal Health (US), Merck Sharp & Dohme Corp (Germany), Boehringer Ingelheim International GmbH (Germnay), Virbac (France), IDEXX Laboratories (US), Vetoquinol (France), Evonik Industries AG (Germany), DuPont (US), DSM (Netherlands), Adisseo (China), BASF SE (Germany), ADM (US), Nutreco (Netherlands), Novusint (US), Cargill Incorporated (US), Charoen Pokphand Group (Thailand), Sumitomo Chemical (Japan), Kemin Industries, Inc. (US), and Medtronic (Ireland) are the Major Companies Operating in Veterinary Pain Management Market.
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Veterinary Pain Management Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.